NextPoint Therapeutics, Inc.
0 followers
NextPoint Therapeutics develops medications to expand the benefit of immunotherapies to cancer patients. The company offers immunotherapies for a validated checkpoint axis that is independent of PD-1/L1 and modulates both adaptive and innate immune systems to find and destroy cancer cells.
Org chart
Paul Conrad
Chief Business Officer, Corporate Secretary/treasurer
Paul Conrad
Collapse
Michael O'Meara
Vice President, Clinical Development Operations
Bijan Etemad-Gilbertson
Vice President, Antibody Technology
Stephanie D.
Director Technical Operations CMC
